These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 16573254)

  • 1. Imatinib mesylate and dermatology part 2: a review of the cutaneous side effects of imatinib mesylate.
    Scheinfeld N
    J Drugs Dermatol; 2006 Mar; 5(3):228-31. PubMed ID: 16573254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse reactions during imatinib and lansoprazole treatment in gastrointestinal stromal tumors.
    Severino G; Chillotti C; De Lisa R; Del Zompo M; Ardau R
    Ann Pharmacother; 2005 Jan; 39(1):162-4. PubMed ID: 15546944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lichenoid drug eruption with palmoplantar hyperkeratosis due to imatinib mesylate: a case report and a review of the literature.
    Kuraishi N; Nagai Y; Hasegawa M; Ishikawa O
    Acta Derm Venereol; 2010; 90(1):73-6. PubMed ID: 20107730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral lichenoid eruption secondary to imatinib (Glivec).
    Ena P; Chiarolini F; Siddi GM; Cossu A
    J Dermatolog Treat; 2004 Jul; 15(4):253-5. PubMed ID: 15764042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pityriasis rubra pilaris-like reaction induced by imatinib.
    Plana A; Carrascosa JM; Vilavella M; Ferrandiz C
    Clin Exp Dermatol; 2013 Jul; 38(5):520-2. PubMed ID: 23777493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lichenoid cutaneous reaction to imatinib].
    Roux C; Boisseau-Garsaud AM; Saint-Cyr I; Hélénon R; Quist D; Delaunay C
    Ann Dermatol Venereol; 2004; 131(6-7 Pt 1):571-3. PubMed ID: 15318140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral and cutaneous lichenoid reaction with nail changes secondary to imatinib: report of a case and literature review.
    Wahiduzzaman M; Pubalan M
    Dermatol Online J; 2008 Dec; 14(12):14. PubMed ID: 19265627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imatinib mesylate-induced maculopapular drug rash.
    Dogra S; Kanwar AJ
    Natl Med J India; 2003; 16(5):285-6. PubMed ID: 14680290
    [No Abstract]   [Full Text] [Related]  

  • 9. Cutaneous reactions to imatinib mesylate treated by topical steroid.
    Ujiie H; Shimizu T; Shimizu H
    Am J Hematol; 2005 Mar; 78(3):246. PubMed ID: 15726597
    [No Abstract]   [Full Text] [Related]  

  • 10. Early and tardive skin adverse events in chronic myeloid leukaemia patients treated with imatinib.
    Breccia M; Carmosino I; Russo E; Morano SG; Latagliata R; Alimena G
    Eur J Haematol; 2005 Feb; 74(2):121-3. PubMed ID: 15654902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute generalized exanthematous pustulosis associated with STI571 in a patient with chronic myeloid leukemia.
    Brouard MC; Prins C; Mach-Pascual S; Saurat JH
    Dermatology; 2001; 203(1):57-9. PubMed ID: 11549802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythema following imatinib mesylate.
    Duncan E; Raj K; Mufti G
    Br J Haematol; 2003 Jul; 122(1):1. PubMed ID: 12823338
    [No Abstract]   [Full Text] [Related]  

  • 13. Oral lichenoid eruption associated with imatinib treatment.
    Gómez Fernández C; Sendagorta Cudós E; Casado Verrier B; Feito Rodríguez M; Suárez Aguado J; Vidaurrázaga Díaz de Arcaya C
    Eur J Dermatol; 2010; 20(1):127-8. PubMed ID: 19825526
    [No Abstract]   [Full Text] [Related]  

  • 14. Imatinib-induced pseudoporphyria.
    Timmer-de Mik L; Kardaun SH; Kramer MH; Hayes DP; Bousema MT
    Clin Exp Dermatol; 2009 Aug; 34(6):705-7. PubMed ID: 19077095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imatinib mesylate induced skin hypopigmentation.
    Talwar V; Doval DC; Bhatia K
    J Assoc Physicians India; 2007 Jul; 55():527. PubMed ID: 17907508
    [No Abstract]   [Full Text] [Related]  

  • 16. Dermatitis after suspected imatinib-levothyroxine interaction in a patient with gastrointestinal stromal tumor.
    Cholongitas E; Pipili C; Katsogridakis K; Relos K; Dasenaki M
    Cancer Chemother Pharmacol; 2008 May; 61(6):1083-4. PubMed ID: 17680243
    [No Abstract]   [Full Text] [Related]  

  • 17. Pityriasis rosea-like eruption during treatment with imatinib mesylate: description of 3 cases.
    Brazzelli V; Prestinari F; Roveda E; Barbagallo T; Bellani E; Vassallo C; Orlandi E; Passamonti F; Borroni G
    J Am Acad Dermatol; 2005 Nov; 53(5 Suppl 1):S240-3. PubMed ID: 16227099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stevens-Johnson syndrome after treatment with STI571: a case report.
    Hsiao LT; Chung HM; Lin JT; Chiou TJ; Liu JH; Fan FS; Wang WS; Yen CC; Chen PM
    Br J Haematol; 2002 Jun; 117(3):620-2. PubMed ID: 12028031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New histopathologic findings in drug eruptions.
    Fitzpatrick JE
    Dermatol Clin; 1992 Jan; 10(1):19-36. PubMed ID: 1530913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heliotrope-like eruption mimicking dermatomyositis in a patient treated with imatinib mesylate for chronic myeloid leukemia.
    Kuwano Y; Asahina A; Watanabe R; Fujimoto M; Ihn H; Tamaki K
    Int J Dermatol; 2006 Oct; 45(10):1249-51. PubMed ID: 17040457
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 27.